For its work on retinitis pigmentosa Nanoscope Technologies has received Orphan Drug Designation from the FDA #visionrestoration#blindness https://t.co/mN6ugv8r3a
For its work on retinitis pigmentosa Nanoscope Technologies has received Orphan Drug Designation from the FDA #visionrestoration#blindness https://t.co/mN6ugv8r3a